{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:28:20Z","timestamp":1790562500670,"version":"4.1.0"},"reference-count":65,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Psychedelic Medicine"],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Approximately 8.5 million Americans over the age of 12 endorsed past year psychedelic use in 2022, with 1.4 million individuals initiating use during this time. Although emerging evidence indicates there may be beneficial aspects of psychedelic use, there is a need to understand how individuals might mitigate potential risks within nonclinical contexts, such as through the use of protective behavioral strategies (PBS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>PubMed and Google Scholar databases were searched to identify articles reporting on PBS (i.e., harm reduction strategies implemented at the individual level) for psychedelic use within nonclinical contexts. We include articles pertaining to both classical serotonergic psychedelics (e.g., lysergic acid diethylamide [LSD], psilocybin) and nonclassical psychedelics (e.g., 3,4-methylenedioxymethamphetamine [MDMA], ketamine).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Although research on psychedelic PBS use is limited, evidence suggests a culture of harm reduction present within psychedelic communities. Psychedelic PBS identified in the literature include strategies related to drug acquisition, dosing, set and setting, bodily nourishment, planning for and working through challenging experiences, and integration of psychedelic experiences. Few studies have examined the relationship between psychedelic PBS use and outcomes, but emerging evidence suggests that psychedelic PBS use may be associated with decreased consequences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>There is a need to continue developing and validating measures of psychedelic PBS and outcomes for use within research and intervention settings. Additional research examining associations between psychedelic PBS use and outcomes is also critical to best serving the needs of individuals who use psychedelics within nonclinical contexts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/psymed.2023.0052","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T04:43:31Z","timestamp":1719981811000},"page":"234-242","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence"],"prefix":"10.1177","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9191-2114","authenticated-orcid":false,"given":"Cianna J.","family":"Piercey","sequence":"first","affiliation":[{"name":"Department of Psychology, Colorado State University, Fort Collins, Colorado, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Gray","sequence":"additional","affiliation":[{"name":"Department of Psychology, Colorado State University, Fort Collins, Colorado, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Psychology, Colorado State University, Fort Collins, Colorado, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Henry","sequence":"additional","affiliation":[{"name":"Department of Psychology, Colorado State University, Fort Collins, Colorado, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollis C.","family":"Karoly","sequence":"additional","affiliation":[{"name":"Department of Psychology, Colorado State University, Fort Collins, Colorado, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"e_1_3_4_2_2","unstructured":"Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health (HHS Publication No. PEP23-07-01-006 NSDUH Series H-58). Center for Behavioral Health Statistics and Quality Substance Abuse and Mental Health Services Administration; 2023. https:\/\/www.samhsa.gov\/data\/report\/2022-nsduh-annual-national-report"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1089\/psymed.2023.0027"},{"key":"e_1_3_4_4_2","unstructured":"Sosa A. Newsom vetoes bill to decriminalize \u2018Magic Mushrooms\u2019 and other psychedelics in California. 2023. Available from: https:\/\/www.latimes.com\/california\/story\/2023-10-07\/gavin-newsom-psychedelics-magic-mushrooms-sb-58-veto-drugs-california [Last accessed: May1 2024]."},{"key":"e_1_3_4_5_2","unstructured":"Levenson M. Pilot who disrupted flight said he had taken psychedelic mushrooms complaint says. 2023. Available from: https:\/\/www.nytimes.com\/2023\/10\/24\/us\/alaska-airlines-off-duty-pilot-arraignment.html [Last accessed: May1 2024]."},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/02698811221116926"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211069100"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116662634"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2018.01.006"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.15493"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1556\/2054.2021.00155"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116678781"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.2005.66.698"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1037\/0893-164X.21.3.307"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1037\/0893-164X.18.4.390"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000498"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2016.77.441"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1037\/adb0000445"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2017.01.007"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1177\/2151458514536969"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","unstructured":"Patrick ME Miech RA Johnston LD et al. Monitoring The Future Panel Study Annual Report:National Data on Substance Use among Adults Ages 19 to 60 1976-2022. Institute for Social Research. 2023.","DOI":"10.7826\/ISR-UM.06.585140.002.07.0002.2023"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103473"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/psymed.2022.0008"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.11.010"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2013.08.011"},{"issue":"2","key":"e_1_3_4_27_2","article-title":"Psychedelic substance use in the reddit psychonaut community","volume":"21","author":"Pestana J","year":"2020","unstructured":"Pestana J, , Beccaria F, , Petrilli E. Psychedelic substance use in the reddit psychonaut community. A Qualitative Study on Motives and Modalities. Drugs Alcohol Today, 2020; 21(2); doi: 10.1108\/DAT-03-2020-0016","journal-title":"A Qualitative Study on Motives and Modalities. Drugs Alcohol Today"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2008.00059.x"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/0022167817709585"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881111420188"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0457-5"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30065-7"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00078"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00662-0"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/02698811231214060"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.01.035"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03399.x"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2016.1141211"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.220"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2950"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.46.5.464"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-012-0929-9"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1177\/2050324516683325"},{"key":"e_1_3_4_44_2","volume-title":"The Psychedelic Explorer\u2019s Guide: Safe, Therapeutic, and Sacred Journeys","author":"Fadiman J","year":"2011","unstructured":"Fadiman J. The Psychedelic Explorer\u2019s Guide: Safe, Therapeutic, and Sacred Journeys. Simon and Schuster; 2011."},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/2050324517711069"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2023.01.073"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1177\/00914509221121420"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1177\/00221678221081380"},{"key":"e_1_3_4_49_2","doi-asserted-by":"crossref","unstructured":"Edwards D Csontos J Pascoe MJ et al. A rapid scoping review of harm reduction strategies for ecstasy (MDMA) users in recreational settings. 2022; doi: 10.21203\/rs.3.rs-2178425\/v1","DOI":"10.21203\/rs.3.rs-2178425\/v1"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2022.2129885"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1089\/psymed.2022.0017"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.645246"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.824077"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4487243"},{"key":"e_1_3_4_55_2","volume-title":"Consciousness Medicine: Indigenous Wisdom, Entheogens, and Expanded States of Consciousness for Healing Healing and Growth","author":"Bourzat F","year":"2019","unstructured":"Bourzat F, , Hunter K. Consciousness Medicine: Indigenous Wisdom, Entheogens, and Expanded States of Consciousness for Healing Healing and Growth. North Atlantic Books; 2019."},{"key":"e_1_3_4_56_2","volume-title":"The Psychedelics Integration Handbook","author":"Westrum PDR","year":"2019","unstructured":"Westrum PDR, , Dufrechou J. The Psychedelics Integration Handbook. Westrum and Dufrechou; 2019."},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119855974"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53829-z"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1080\/00048670701449237"},{"key":"e_1_3_4_60_2","doi-asserted-by":"crossref","unstructured":"Boness CL Hebden H Lardier DT et al. Engaging People with Lived Experience of Psychological Disorders in Measure Development: Current Research and Future Directions for Psychological Science. 2023.","DOI":"10.31234\/osf.io\/gmpfa"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2013.03.010"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003149"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.05.020"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000301"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1037\/a0038902"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjhp.12535"}],"container-title":["Psychedelic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/psymed.2023.0052","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/psymed.2023.0052","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/psymed.2023.0052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T01:27:21Z","timestamp":1777685241000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/psymed.2023.0052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12,1]]}},"alternative-id":["10.1089\/psymed.2023.0052"],"URL":"https:\/\/doi.org\/10.1089\/psymed.2023.0052","relation":{},"ISSN":["2831-4425","2831-4433"],"issn-type":[{"value":"2831-4425","type":"print"},{"value":"2831-4433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}